{"organizations": [], "uuid": "a840053dbf89711c958101e3f0da7b197c04043e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-perrigo-announces-tentative-fda-ap/brief-perrigo-announces-tentative-fda-approval-for-the-generic-version-of-soolantra-cream-1-idUSASB0C2ZB", "country": "US", "domain_rank": 408, "title": "BRIEF-Perrigo Announces Tentative FDA Approval For The Generic Version Of Soolantra Cream, 1%", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-30T15:38:00.000+02:00", "replies_count": 0, "uuid": "a840053dbf89711c958101e3f0da7b197c04043e"}, "author": "", "url": "https://www.reuters.com/article/brief-perrigo-announces-tentative-fda-ap/brief-perrigo-announces-tentative-fda-approval-for-the-generic-version-of-soolantra-cream-1-idUSASB0C2ZB", "ord_in_thread": 0, "title": "BRIEF-Perrigo Announces Tentative FDA Approval For The Generic Version Of Soolantra Cream, 1%", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "soolantra cream", "sentiment": "negative"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "perrigo", "sentiment": "none"}, {"name": "perrigo company plc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 30, 2018 / 1:39 PM / in 11 minutes BRIEF-Perrigo Announces Tentative FDA Approval For The Generic Version Of Soolantra Cream, 1% Reuters Staff 1 Min Read \nJan 30 (Reuters) - Perrigo Company Plc: \n* PERRIGO ANNOUNCES TENTATIVE FDA APPROVAL FOR THE GENERIC VERSION OF SOOLANTRAÂ® CREAM, 1% Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-30T15:38:00.000+02:00", "crawled": "2018-01-30T15:52:50.015+02:00", "highlightTitle": ""}